SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-149976
Filing Date
2021-05-04
Accepted
2021-05-04 16:02:00
Documents
14
Period of Report
2021-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d178980d8k.htm   iXBRL 8-K 24561
2 EX-99.1 d178980dex991.htm EX-99.1 61903
6 GRAPHIC g178980dsp1.jpg GRAPHIC 2773
  Complete submission text file 0001193125-21-149976.txt   222297

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arvn-20210504.xsd EX-101.SCH 3092
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20210504_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20210504_pre.xml EX-101.PRE 11422
7 EXTRACTED XBRL INSTANCE DOCUMENT d178980d8k_htm.xml XML 3354
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 21888297
SIC: 2834 Pharmaceutical Preparations